AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04884659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: usual feeding pattern arm
Description: All meals consumed ad lib with 50% of calories consumed after 4PM
Study NCT04959058 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Volunteer
Description: An ultrasound machine will be used to calculate the elastographic value of the brachial plexus in three different positions.
Study NCT04593511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY03009 F1
Description: a single dose of LY03009 F1
Study NCT04593511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY03009 F2
Description: a single dose of LY03009 F2
Study NCT04593511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY03009 F3
Description: a single dose of LY03009 F3
Study NCT04593511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY03009 F4
Description: a single dose of LY03009 F4
Study NCT05043025 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Identification of the cricothyroid membrane
Description: The cricothyroid membrane is identified using a laryngeal handshake technique in different patient positions.
Study NCT05043025 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Identification of the cricothyroid membrane
Description: The cricothyroid membrane is identified using a laryngeal handshake technique in different patient positions.
Study NCT06419842 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hypnosis
Description: the patient benefits from a dedicated nurse consultation. During this consultation, the nurse will explain the highlights of the hospitalization, the procedure and anticipate the hypnosis technique to be used. The technique chosen during the consultation will be applied during the test. The nurse is positioned at the head of the patient and with physical contact.
Study NCT06419842 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: comfort
Description: the patient benefits from a nurse consultation. Non-medicinal techniques are not offered. During the infusion test, the nurse will be positioned at the patient's head allowing proximity but without oral or physical intervention.
Study NCT06383234 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LG-TAP block with local anesthetic
Description: The laparoscopic guided TAP Block was performed by surgeon at the beginning of surgery, injecting 15 ml of Ropivacaine 0.5% on each side, using an atraumatic needle (10/15 cm length, 20 Gauge diameter) close to the anterior axillary line, between the iliac crest and the subcostal margin. Correct needle tip positioning between the transverse muscle of the abdomen and the internal oblique was verified through laparoscopic guidance.
Study NCT06383234 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: LG-TAP block with saline solution
Description: The laparoscopic guided TAP Block was performed by surgeon at the beginning of surgery, injecting 15 ml of Saline solution (NaCl 0.9%) on each side, using an atraumatic needle (10/15 cm length, 20 Gauge diameter) close to the anterior axillary line, between the iliac crest and the subcostal margin. Correct needle tip positioning between the transverse muscle of the abdomen and the internal oblique was verified through laparoscopic guidance.
Study NCT06383234 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Port site infiltration
Description: Prior the surgical incision, an infiltration of the laparoscopic access using a total of 10 ml Ropivacaine 0.5% was performed by surgeon
Study NCT06383234 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Port site infiltration
Description: Prior the surgical incision, an infiltration of the laparoscopic access using a total of 10 ml Ropivacaine 0.5% was performed by surgeon
Study NCT05423496 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: KidneyCare
Description: Using KidneyCare platform as a tool to successfully augment immunosuppressant agents through regular surveillance allowing minimization of doses and number of agents.
Study NCT06085274 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ICG guided sentinel lymph node biopsy
Description: During sentinel lymph node biopsy the surgeon will inject a volume of 0.1ml divided into 2 doses (0.05ml each) of 2.5mg/mL ICG into the periareolar dermis of the involved breast. Technetium and blue dye will also be administered as per standard of care. The surgeon will assess the axilla with the the SPY-PHI near infrared imaging system to identify and remove ICG-fluorescent nodes; Any other sentinel lymph nodes identified will also be removed as per standard of care. If there is no progression of ICG towards the axilla, or if no ICG sentinel lymph node can be identified, an alternate injection technique involving peritumoural injection at 2-3 locations near the cancer site in the subcutaneous or dermal space of 0.05ml will be utilized.
Study NCT05423496 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: KidneyCare
Description: Using KidneyCare platform as a tool to successfully augment immunosuppressant agents through regular surveillance allowing minimization of doses and number of agents.
Study NCT05423496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: steroid
Description: optimization of steroids
Study NCT05423496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MMF
Description: optimization of MMF
Study NCT05407454 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: The original form of the Diabetes Quality of Life-Brief Clinical Inventory was first developed in 1999 to establish a valid and reliable form of diabetes-specific quality of life. Inventory items were developed to address the issues that have the greatest impact on assessing patient self-care behaviors and satisfaction with diabetes care. Items are ranked on a 5-point Likert scale and are in two general formats. One format includes satisfaction with treatment and quality of life and is scored from 1 (very satisfied) to 5 (not very satisfied). The second format includes the frequency of adverse effects of diabetes itself or diabetes treatment and offers response options from 1 (never) to 5 (always). Therefore, higher scores on the DQL-BCI items and subscales include negative values indicating problem frequency or dissatisfaction. In order to use the DQL scale more efficiently in clinics, Burroughs et al. organized the 15-item DQL-BCI in 2004.
Study NCT05936931 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Changes in CRC screening awareness and intentions
Description: Using a single arm, open-label, pre-test post-test design (n=15 adult child/parent dyads), assess the impact of a young adult-mediated intervention to increase CRC screening among a paired age-eligible family member (e.g., parent/grandparent). The focus of the intervention will be on changes in CRC screening awareness and intentions among the age-eligible adult, but we hypothesize that the young adult could benefit as well. Thus, in addition to assessing feasibility and acceptability, we will assess changes in 1) CRC screening intentions among the age-eligible adults and 2) CRC health literacy and awareness of screening guidelines among the younger adult participant.
Study NCT06049264 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thoracic spine manual traction with mobilization protocol.
Description: The therapist will perform one 30-second bout of grade I or II central posterior-anterior mobilization at the T3 spinous process as described by Maitland et al. After the 30-second bout, the therapist proceeded to T4 and performed the same technique. This process was continued sequentially in a caudal direction to T8, for an overall intervention time of approximately 3 minutes. In addition to mobilization, thoracic spine traction will be also given in sitting position.
Study NCT06049264 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic manipulation protocol
Description: To perform the manipulation, the stabilizing hand will be placed at the level immediately caudal to the restricted segment using a ''pistol grip''. Once the pre manipulative position will be achieved the patient will be instructed to take a deep inhalation and exhale. During the exhalation the treating clinician performed a high velocity, small amplitude thrust in a direction to facilitate relative closing or opening of the respective facet joint as indicated by the segmental examination.
Study NCT05346003 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TCSP
Description: In the pre-test, all students will be given a BLS information form, followed by blended e-learning with theory and video in a virtual environment. The BLS knowledge post-test will be administered immediately after class.T-shirts and standard pillows (550 g silicon fiber pillow 50x70 cm size) with a simulation of an adult human size (approximately) sternum, rib and heart drawing (printed as picture) will be given to the intervention group only after the pretest. In the study, the BLS will be simulated for adult patients only. To simulate a half-body human BLS mock-up, a pre-made simulation t-shirt will be fitted on a standard pillow to create a BLS mock-up in a home environment, and after blended e-learning, they will be able to perform BLS iteratively on a T-shirt-clad simulation pillow (TCSP) model. In this way, autonomous learning will be supported. All students will practice BLS in a real simulation model two weeks after the blended e-learning.
Study NCT05374226 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JS019
Description: Four dose levels are preset: 0.3 mg/kg, 1 mg/kg, 3 mg/kg, and 10 mg/kg. The subjects are treated with JS019 by intravenous infusion, once every 3 weeks (Q3W). A treatment cycle is 21 days, and the DLT observation period is 21 days after the first administration.
Study NCT05541055 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital CBT-I
Description: A fully-automated and personalized digital intervention based on principles from cognitive behavioral therapy for insomnia.
Study NCT05541055 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sleep hygiene education
Description: Participants will be provided with sleep hygiene advice which will be delivered digitally all at once upon allocation to the SHE arm. Participants will be able to revisit content during the trial as they wish.
Study NCT05577208 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Symplicity Spyral multi-electrode renal denervation catheter and Symplicity G3 generator (Renal Denervation System)
Description: Minimally invasive percutaneous interventional therapy aimed to modulate the sympathetic nervous system through endovascular ablation of both renal arteries
Study NCT05624879 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Accelerated Resolution Therapy
Description: A brief psychotherapeutic intervention delivered by trained therapists in a maximum of 4 sessions. Sessions will focus on providing relief from the distress related to an anticipated loss and to shift focus from distress and loss back to the relationship.
Study NCT05624879 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Information and Support
Description: 4 sessions of a standardized social work intervention. Standard of care including education and active listening.
Study NCT05025657 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: ALLY
Description: ALLY is a universal, school-based prevention program that takes place during the school day with individual students over 6 weeks.
Study NCT05025657 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALLY
Description: ALLY is a universal, school-based prevention program that takes place during the school day with individual students over 6 weeks.
Study NCT06145243 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home based exercise
Description: Patients will be given a visual brochure with pictures explaining the exercises. Patients will perform the resistance exercises in the given exercise program for 8 weeks, 2 days a week for 8-12 repetitions and 3 sets using resistance bands.Progress of the home exercise group will be checked by phone every week.
Study NCT06145243 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Video-based resistive exercise
Description: A video recording of the exercises will be taken and given to the patients as a video recording.Patients will perform the resistance exercises in the given exercise program for 8 weeks, 2 days a week for 8-12 repetitions and 3 sets using resistance bands.Progress of the video-based exercise group will be checked by phone every week.
Study NCT06145243 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervised resistive exercise
Description: Patients will perform their exercises under the supervision of a physiotherapist.Patients will perform the resistance exercises in the given exercise program for 8 weeks, 2 days a week for 8-12 repetitions and 3 sets using resistance bands.
Study NCT05461976 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based self-management exercise program
Description: Session 1 will includes education about stroke. Session 2 will includes feedback on behaviour performance on initial measurement outcomes, health consequences of the physical inactivity, answering an exercise preferences questionnaire, generation of a list of goals, delivering a smartband and a diary to self-monitoring. Session 3 will includes reviewing of goals and strategies to self-monitoring, encouragement, rising barriers to exercise and potential solutions to them, development of a weekly schedule physical exercise, implementation of the physical exercise session with participant and delivering a paper-exercise guide. Session 4 will includes reviewing of goals and weekly schedule physical exercise, encouragement, problem solving/coping planning, reviewing strategies to self-monitoring and showing to participant a video with another stroke survivors which are physically active. Sessions 5 and 6 will be the same as session 4 with exception of vicarious reinforcement.
Study NCT05527366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vagus stimulation
Description: The Vagus Stimulation Group received auricular vagus stimulation for a total of 15 sessions of 25 minutes 5 days a week. The patients were applied with vagustim device consisting of TENS device with electrodes placed bilaterally in the outer ear with headphones that can be selected according to ear size. During the application, the gel was used to avoid causing any damage and to ensure conductivity. It is placed so that tragus and konkaya are facing. The pulse duration of the TENS device is less than 500 microseconds, the frequency is 10 Herzt, the module was applied in TENS mode and in the form of a biphasic asymmetric wave.
Study NCT05527366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Consevative treatment
Description: A total of 15 sessions 5 days a week, 20 minutes of hotpack, 20 minutes of TENS, 5 minutes of 1,3 watt/cm2 ultrasound consisting of a total of 25 minutes of treatment was applied to the neck area.
Study NCT05021510 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simultaneous Cervical Traction & Neural Mobilization
Description: Simultaneously Mechanical Cervical traction with Neural Mobilization of the upper limb for 3 times a week, 45 minutes per day for 4 weeks
Study NCT05021510 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: consecutive Cervical Traction & Neural Mobilization
Description: consecutive Mechanical Cervical traction with Neural Mobilization of the upper limb for 3 times a week, 45 minutes per day for 4 weeks
Study NCT05055102 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: demographics co-morbidities risk factors operative, hospital and vascular follow-up data
Study NCT00696358 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: 308nm excimer lamp
Description: 50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks
Study NCT00696358 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: 308nm excimer laser
Description: 50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks (same doses will be used between the 2 arms)
Study NCT05966857 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wearable: Smartwatch
Description: The SAMSUNGTM Galaxy Watch5 Smartwatch, is a new generation of smartwatches, features an innovative 3-in-1 BioActive sensor, which uses a chip to capture optical and read cardiac electrical current, allowing to carry out high-quality real-time single-lead electrocardiogram. Despite the more compact design, there is no decrease in accuracy. These signals are then processed by the device's algorithms and can be sent to a trained professional for evaluation immediately after the measurement, facilitating the monitoring and diagnosis of arrhythmias.
Study NCT05816330 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: L9LS (VRC-MALMAB0114-00-AB)
Description: Administered one time via subcutaneous route.
Study NCT05816330 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: Administered one time via subcutaneous route.
Study NCT06169774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational video
Description: Watch the 17-minute educational video as many times as needed within a 12-month period.
Study NCT06009523 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: 1 stimulation per day during 15 days.
Study NCT03275974 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Carbon C 11 Glutamine
Description: Given by IV
Study NCT03275974 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fluorine F 18 L-glutamate Derivative BAY94-9392
Description: Given by IV
Study NCT03275974 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET scan
Study NCT03275974 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood Draw
Description: Undergo venous blood draws
Study NCT05234736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBL-514
Description: CBL-514 800 mg (unit dose: 2.0 mg/cm\^2)
Study NCT04821609 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance Training
Description: The resistance training will be for arms and legs, self-loading type, and external weights.
Study NCT06173037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC88
Description: 2.0 mg/kg Q3W IV
Study NCT05903105 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Patients fill in a questionnaire
Study NCT04929392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT04929392 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Biopsy
Description: Undergo endoscopic biopsy
Study NCT04929392 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Radiation Therapy
Description: Undergo EBRT
Study NCT04929392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib Mesylate
Description: Given PO
Study NCT04929392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV
Study NCT04929392 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT04929392 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection
Description: Undergo surgical resection
Study NCT05677256 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: nOPV2
Description: Vaccination
Study NCT05677256 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: nOPV2
Description: Vaccination
Study NCT06098339 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens A (fanfilcon A)
Description: Daily wear for one month
Study NCT06098339 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens B (lotrafilcon B)
Description: Daily wear for one month
Study NCT05519644 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation
Description: The sleeping protocol will be monitored by investigators and personnel with experience in sleep medicine. Participants will be required to reduce sleep by 50% of normal, for 4 consecutive nights, to observe potential deficits in physical and cognitive performance
Study NCT05519644 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sleep Deprivation
Description: The sleeping protocol will be monitored by investigators and personnel with experience in sleep medicine. Participants will be required to reduce sleep by 50% of normal, for 4 consecutive nights, to observe potential deficits in physical and cognitive performance
Study NCT05519644 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heart Rate
Description: HR will be assessed by wrist-based acceleration with cloud technology (Polar Unite™, Polar USA). This monitor is less burdensome than other sleep monitoring technologies and less likely to interfere with normal sleep and activity demands of the cadets. Each participant will be fitted with the watch for acclimatization and then establish 3-day baseline patterns for 3 nights before the sleep loss protocol.
Study NCT05519644 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Heart Rate
Description: HR will be assessed by wrist-based acceleration with cloud technology (Polar Unite™, Polar USA). This monitor is less burdensome than other sleep monitoring technologies and less likely to interfere with normal sleep and activity demands of the cadets. Each participant will be fitted with the watch for acclimatization and then establish 3-day baseline patterns for 3 nights before the sleep loss protocol.